HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.
about
Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment optionsNAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsSignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaHepatitis C genotype 4: The past, present, and futureClinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis CInfection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Global epidemiology and burden of HCV infection and HCV-related disease.Hepatitis C genotype 3 disease.APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscapeBiophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase.Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study.Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus.Translating RNA sequencing into clinical diagnostics: opportunities and challenges.Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosisShould NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?Hepatitis C virus-induced hepatocellular carcinomaChanges in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES.Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.How do persistent infections with hepatitis C virus cause liver cancer?Hepatitis C genotype influences post-liver transplant outcomesClinical Features and Outcomes of Patients With Genotype 3 Hepatitis C Virus Infection in Korea: A Retrospective Observational Study.Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C.Treatment of Hepatitis C Virus Genotype 3 InfectionIs exposure to Agent Orange a risk factor for hepatocellular cancer?-A single-center retrospective study in the U.S. veteran population.Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment StrategiesRisk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging Populations.Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among NonrespondersHepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution.Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'.The evolving epidemiology of hepatocellular carcinoma: a global perspective.Management of HCV in cirrhosis-a rapidly evolving landscape.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection.Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents.Optimum combination therapy regimens for HIV/HCV infection.Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
P2860
Q24658456-A5218034-A678-4CAF-9E55-345949A18DA3Q26745576-6D19C6E3-4749-4AAA-A605-174C456A9F44Q26773251-5252B4BB-9728-46DD-B6BC-40B810F85474Q26775815-92EC4A3D-1099-4DCF-805D-2BA0552BD4F5Q28080225-ED54D31B-D80F-47EA-84CF-9EB933C497F1Q30151690-31278BE2-05D5-45A4-B918-9567FA5A4A9FQ30240220-EA6BB47C-7689-48C3-A7B7-E900D9DA28CAQ30244065-49A7A070-C380-47BA-B42D-150C9B9A17BEQ30250088-43E41D68-8DE0-41CE-AF4A-DBD6BB50431BQ31012317-84B38D60-A25D-4F50-9094-4913A9DDFC46Q32183060-DEA7E185-A243-491F-88C5-0299C0618B3DQ33621731-3229445B-288B-4454-87D2-CB95302DFE7AQ33922932-379FB82F-0AD1-42DF-85FA-4D7FB627982AQ34519034-51ED8C0F-232F-497A-B092-6EB3504A8EE5Q35172318-BB23861D-A90F-4AB8-824E-75B71C567520Q35194406-1DB657E8-6E7F-4239-9A26-F16634558C42Q35491398-F0B6AD0D-8795-4939-A8ED-99E288AD4322Q35824057-2B71084A-8621-44E4-A90E-4A7DDB58AC19Q35838417-73BE0F06-2FF9-41A5-BAFC-A6A890DA4CBFQ36199751-ECED8E41-E1B8-4638-A579-333646B17FAFQ36236839-41726291-EF26-4F21-A2AD-9E2D9D8E90DAQ36354472-1845A1E2-44EE-4A4D-9B69-47CD2473C4E2Q36581068-26E9A050-DD20-4AC6-8004-D134CE4E3709Q36716281-DFBDB599-6931-4CEF-B239-8F9112006620Q36848475-510D4CDD-BBCE-463B-8365-E9A397449E2FQ36937018-2486C9BB-4036-45B5-B861-998BCF1F5878Q36981033-A2EBE621-D412-4EB7-ADB6-A41FE27BCD13Q37029846-8F390BAD-3141-403A-86A6-1726778D36A3Q37555313-AF9B5760-91A9-4A5E-8287-0A8BE53BAB3FQ37641036-C16EA24E-0723-42C0-8FEA-7EBABF6DAF67Q37663438-1B7ED1A0-6318-4ADC-AA4C-3A41AF741370Q38249236-80FA875B-7538-49E5-87BF-72F972B2658CQ38397998-637E58F3-D614-41D9-BDEA-9533EFB68A09Q38432047-A9135CCF-EC7C-4C31-A350-DD2169BE964FQ38515906-674CBF2F-7C71-4B61-9D8A-55042AE24FC7Q38631256-C491C3E4-33D7-4B50-957E-A43E02123A3DQ38637199-83259F5B-A9B1-4BDC-90B4-F8A8FBB2A792Q38715477-08921767-DBF6-4FED-8870-1A98F3CCEB19Q38728564-E0D0C17C-31A1-4013-B949-8FEE2392C9C5Q38735317-15AFF93A-004C-4F8C-8E28-1866D4B0611D
P2860
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
HCV genotype 3 is associated w ...... ple of U.S. Veterans with HCV.
@ast
HCV genotype 3 is associated w ...... ple of U.S. Veterans with HCV.
@en
type
label
HCV genotype 3 is associated w ...... ple of U.S. Veterans with HCV.
@ast
HCV genotype 3 is associated w ...... ple of U.S. Veterans with HCV.
@en
prefLabel
HCV genotype 3 is associated w ...... ple of U.S. Veterans with HCV.
@ast
HCV genotype 3 is associated w ...... ple of U.S. Veterans with HCV.
@en
P2093
P2860
P356
P1433
P1476
HCV genotype 3 is associated w ...... ple of U.S. Veterans with HCV.
@en
P2093
Fasiha Kanwal
Hashem B El-Serag
Jawad Ilyas
Jennifer R Kramer
Zhigang Duan
P2860
P304
P356
10.1002/HEP.27095
P407
P577
2014-05-27T00:00:00Z